 |
Biotech Investment Products |
Biotech Investing |
Biotechnology Research |
About Us |  |
 | HOW TO INVEST |
| SUITABILITY & RISKS |
| ARE YOU AN ACCREDITED INVESTOR? |
- Market Growth from 2004 to 2010
-
HEM hematology;
ONCO, oncology;
D&E, Diabetes and endocrinology;
ID*, infectious diseases including HIV;
AIID, Arthritis inflammation and immune disorders;
CNS, central neural system;
GD, genetic disorders;
WH, woman's health.
Others**, respiratory plus cardiovascular;
Source: Datamonitor and company-reported information.
Nature Publishing Group
Nature Biotechnology
Sitemap | Homepage | Who We Are | Why Biotech? | Why Biotech Investing? | Venture Capital | Private Equity | How to Invest
Top Biotech Companies | Biotech Research | Biotech Investing Facts | About Biotech Investing | Clinical Trial Process | Contact Us
© 2001-2010 InvestBio, Inc., a subsidiary of Diversified Private Equity Corporation (DPEC). All rights reserved. InvestBio is a registered trademark. All investments offered through DPEC Capital, Inc (Member FINRA/SIPC/SIFMA).